Award NoticePosted Sep 18, 2025

Casualty Care Assessment of Russo-Ukraine War

Defense Health Agency · ARMY MED RES ACQ ACTIVITY

Stage
Awarded
NAICS
541715
Value
$4.0M
Solicitation
HT942525PE041
Set-aside
No Set aside used
PSC
AN11
Place
Frederick, MD, USA
Contact
Elizabeth O'Hara, Contract Specialist (elizabeth.m.ohara3.civ@health.mil)

No listed company matched (Materiality N/A)

Loading your pipeline and notes…
CSV Email

Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.

Where this opportunity stands

Every notice posted under solicitation HT942525PE041 in this department, oldest first.

Early notice
None posted
Solicitation
None posted
Award
  • Sep 18, 2025 · this notice
    Award Notice
    THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. · $4.0M

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

  • Note the winner and the end of the period of performance for the recompete.
  • Follow the agency to see the next notice for this work.

What the notice says

The U.S. Army Medical Research Acquisition Activity (USAMRAA) in support of the Defense Health Agency (DHA), Research & Engineering (R&E) Directorate, Combat Casualty Care (CCC) Portfolio awarded a contract to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc (6720A Rockledge Dr STE 100, Bethesda, Maryland 20817-1891) resulting from solicitation HT9425-25-R-E026 for Casualty Care Assessment of Russo-Ukraine War. This award will provide continued Research and Development to the Casualty Care Assessment of Russo-Ukraine War. The period of performance is 12-months.

Who won similar work

3 award notices on SAM.gov in the last 24 months. Matched by: Same office (ARMY MED RES ACQ ACTIVITY), same NAICS 541715.

Single-winner award sizes (3): middle half $6.4M to $18.8M, median $12.5M; range $314K to $25.0M.

WinnerAwardsValueLast
CHICKASAW SERVICE SOLUTIONS, LLC1$25.0MDec 20, 2024
HEMOGLOBIN OXYGEN THERAPEUTICS LLC1$12.5MMay 28, 2025
FLORIDA INSTITUE FOR HUMAN MACHINE COGNITION INC1$314KAug 26, 2025

Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.

Latest awards

Competitive landscape

For the 3 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

  • 0 of these past winners lobbied Defense, Dept of (DOD) or Office of the Secretary of Defense or Joint Chiefs of Staff since 2024 (0 filings)
  • 0 of their lobbyists list a past Defense, Dept of (DOD) or Office of the Secretary of Defense or Joint Chiefs of Staff job
  • No corporate PAC money from them to the overseeing committees since 2024
  • 0 foreign-agent (FARA) registrations
See who and the source records with Pro

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

  • 0 bills named on the past winners' lobbying filings
  • 32 rules from the department in the last 12 months
  • 0 executive orders naming the agency in the last 12 months
See who and the source records with Pro

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.

  • 0 of the past winners are listed companies
  • 0 insider buys and 0 insider sells at them in the last 90 days
See who and the source records with Pro

Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.

Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.